Geographic variation in diagnosis, medication use and associated costs of attention deficit disorder (ADD)

Full Text

PGI37 - UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C MANAGED BY THE HOSPITAL PHARMACY- CONTRIBUTIONS TO PUBLIC HEALTH AND PUBLIC EXPENDITURE

Abstract

Authors

A. Figueira I. Gomes C. Sequeira S. Silva F. Machado J. Figueiredo E. Rabadão P. Dinis V. Andreozzi B. Vandewalle J. FÃ©lix A. Feio

Back to Volume 21, Supplemental S3

PGI37 - UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C MANAGED BY THE HOSPITAL PHARMACY- CONTRIBUTIONS TO PUBLIC HEALTH AND PUBLIC EXPENDITURE

Abstract

Authors

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date